SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,314.59 -21.86
( -0.03%)

Global Indices

Nasdaq

51,493.09 -621.02
(-1.19%)

Dow Jones

7,573.47 -33.26
(-0.44%)

Hang Seng

63,960.24 37.24
(0.06%)

Nikkei 225

10,816.25 127.78
(1.20%)

Forex

USD-INR

95.42 0.14
(0.14%)

EUR-INR

110.10 0.01
(0.01%)

GBP-INR

128.62 0.03
(0.02%)

JPY-INR

0.62 0.00
(-0.26%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Bafna Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532989

INE878I01022

40.6443073

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BAFNAPH

94.22

733.35

EPS(TTM)

Face Value()

Div & Yield %

3.29

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	150.62	145.86	152.47	115.35	85.14	71.22
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	150.62	145.86	152.47	115.35	85.14	71.22
Other Income	4.76	2.74	3.52	3.27	1.70	0.75
Stock Adjustments	0.16	-6.45	4.85	2.91	1.77	-2.95
Total Income	155.54	142.15	160.84	121.53	88.61	69.02
EXPENDITURE :
Raw Materials	82.14	74.49	91.58	65.98	41.70	33.58
Power & Fuel Cost	7.30	7.72	6.73	5.31	3.93	2.95
Employee Cost	21.92	21.03	19.03	15.87	14.65	11.98
Other Manufacturing Expenses	13.52	14.83	13.83	8.68	7.72	6.72
Selling & Administrative Expenses	9.56	9.37	13.98	5.39	6.92	2.67
Miscellaneous Expenses	0.40	2.94	1.06	1.33	2.19	0.07
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	134.83	130.38	146.20	102.55	77.11	57.97
Operating Profit	20.70	11.77	14.63	18.99	11.50	11.04
Interest	3.66	2.73	2.29	2.04	0.79	0.74
Gross Profit	17.04	9.04	12.34	16.95	10.71	10.30
Depreciation	6.07	4.89	5.00	5.33	5.49	4.48
Profit Before Tax	10.97	4.15	7.34	11.62	5.22	5.82
Tax	-0.13	0.00	0.00	0.28	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Net Profit	11.10	4.15	7.35	11.34	5.22	5.83
Extraordinary Items	0.00	-2.22	0.07	0.20	-2.16	0.00
Adjusted Net Profit	11.10	6.37	7.28	11.14	7.38	5.83
Adjustment below Net Profit	0.00	0.00	0.04	0.15	-0.02	0.00
P & L Balance brought forward	-43.11	-47.26	-54.48	-65.97	-71.17	-76.99
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-32.01	-43.11	-47.10	-54.48	-65.97	-71.17
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	4.69	1.76	3.11	4.79	2.21	2.46
Earnings Per Share(Adj)-Unit Curr	4.69	1.76	3.11	4.79	2.21	2.46
Book Value-Unit Curr	40.64	35.85	34.17	31.05	26.19	24.00
Book Value(Adj)-Unit Curr	40.64	35.85	34.17	31.05	26.19	24.00

74,314.59 -21.86 ( -0.03%)

51,493.09 -621.02 (-1.19%)

7,573.47 -33.26 (-0.44%)

63,960.24 37.24 (0.06%)

10,816.25 127.78 (1.20%)

95.42 0.14 (0.14%)

110.10 0.01 (0.01%)

128.62 0.03 (0.02%)

0.62 0.00 (-0.26%)